[Article] Investigating the origins of recent pharmaceutical innovation

Using Market-Exclusivity Incentives to Promote Pharmaceutical ...

... innovation that contributes to new drug development. However, this system also has important implications for public health. For example, when patented ...

Where Drugs Come From: The Numbers | Science | AAAS

A new paper in Nature Reviews Drug Discovery takes on all 252 drugs approved by the FDA from then through 2007, and traces each of them back to their origins.

Does Adoption of Pharmaceutical Innovation Respond to Changes ...

Abstract This paper investigates how regulation impinged on the launch strat egies of international pharmaceutical corporations for new molecules across the.

Lessons From the Rise and Fall of Japan's Life-Sciences Innovation ...

And so what you will find is that today startups only account for 2% of new drug innovation in Japan compared to in the United States, where ...

Pharmaceutical Innovation and Access to Medicines - OECD

However, sustainable access to innovative medicines is a source of growing concern. The high prices of many new medicines are hitting media ...

The Effect of Pharmaceutical Innovation on Longevity: Patient-Level ...

We investigate the effect of the vintage (year of FDA approval) of the prescription drugs used by an individual on his or her survival and medical expenditure.

Insurance Design and Pharmaceutical Innovation

This paper studies how insurance coverage policies impact pharmaceutical innovation. In the United States, most patients obtain prescription drugs through ...

The Impact of the Inflation Reduction Act of 2022 on Pharmaceutical ...

... Pharmaceutical Innovation, Patent Litigation and Market Entry ... New price setting provisions built into the IRA may impact research ...

The Government and Pharmaceutical Innovation: Looking Back and ...

... source, articles without this flag do not necessarily come from industry. ... New England Journal of Medicine 364, no. 6 (2011): 535-541 ...

Patents and New Product Development in the Pharmaceutical and ...

John Vernon and I have investigated the effects of the 1984 act on both generic competition and effective patent lifetimes.30 In this paper, I have sum- marized ...

Market Size in Innovation: Theory and Evidence from the ...

Abstract. This paper investigates the effect of (potential) market size on entry of new drugs and pharmaceutical innovation. Focusing on exogenous changes.

Drug companies keep merging. Why that's bad for consumers and ...

The end result of now three waves of pharmaceutical consolidation is decreased or diverted new drug innovation, fewer treatment options and ...

U.S. Food and Drug Administration

The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, ...

A new list ranks large pharmaceutical companies by R&D

Here's a look at the annual list produced by Idea Pharma and called the Pharmaceutical Innovation and Invention Index.

35 Years of Innovation - History of Regeneron Pharmaceuticals

... new medicines to patients. Learn more about our history of innovation in biotechnology ... Science publishes our first paper, which becomes the most highly cited ...

US Tax Dollars Funded Every New Pharmaceutical in the Last Decade

With support from the Institute for New Economic Thinking, we have recently completed a Working Paper examining the public sector investments by ...

4 of the latest trends in pharmaceutical innovation - Within3

According to research in the National Library of Medicine, “Blockchains can be used to trace the origin of pharmaceuticals, the transport of drugs, and the ...

Pharmaceutical Innovation: Revolutionizing Human Health (review)

Journal of the History of Medicine and Allied Sciences · Oxford University ... new drug introductions after the early 1960s. One reason not cited by the ...

Pharmaceutical Innovation - Search eLibrary :: SSRN

... investigation of new drug -- permit. The clinical phase is in turn conventionally divided into three main phases. In Phase I, the drug is.

The impact of pharmaceutical innovation on cancer mortality in ...

By the standards of the World Health Organization, new cancer drugs have been very cost-effective in Mexico. The contribution of cancer drug ...